The effect of Crocus Sativus L.(saffron) on the intensity of PMS in the female university students

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT138807292618N1

Enrollment

Registered

2010-02-05

Start date

2010-04-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premenstrual syndrome. Premenstrual tension syndrome

Interventions

Intervention 1: C.Sativus capsule, 30 mg/day (15 mg, twice a day) for 8 weeks. Intervention 2: Placebo capsule (twice a day) for 8 weeks.

Treatment - Drugs

Placebo

C.Sativus capsule, 30 mg/day (15 mg, twice a day) for 8 weeks

Placebo capsule (twice a day) for 8 weeks

Eligibility

Sex/Gender

Female

Age

18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age 18-35 years, residence in dormitory, having regular menstrual cycles, experience of PMS symptoms. Exclusion criteria: pregnancy, lactation, menstrual cycle irregularity, medical disease, hormonal method of contraception

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Intensity of the premenstrual syndrome. Timepoint: daily. Method of measurement: premenstrual assessment form.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSoheila Pirdadeh Beiranvand

Lorestan Unuversity of Medical Sciences

kimia_n72@yahoo.coms.pirdadeh@lums.ac.ir+98 66 1322 9095

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026